Evidence map›Paper›PMID 18645513›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2008

Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial.

Susan Tross, Aimee N C Campbell, Lisa R Cohen, Donald Calsyn, Martina Pavlicova, Gloria M Miele, Mei-Chen Hu, Louise Haynes, Nancy Nugent, Weijin Gan and 6 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. HIV Risk Reduction Interventions Among Substance-Abusing Reproductive-Age Women: A Systematic Review.AIDS education and prevention : official publication of the International Society for AIDS Education · 2017
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Impact of interim methadone maintenance on HIV risk behaviors.Journal of urban health : bulletin of the New York Academy of Medicine · 2010
    Trial
  19. Trial
  20. Trial

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Susan TrossDepartment of Psychiatry, HIV Center for Clinical and Behavioral Studies, Columbia University Medical Center, New York, NY 10032, USA. st130@columbia.edu
Aimee N C Campbell
Lisa R Cohen
Donald Calsyn
Martina Pavlicova
Gloria M Miele
Mei-Chen Hu
Louise Haynes
Nancy Nugent
Weijin Gan
Mary Hatch-Maillette
Raul Mandler
Paul McLaughlin
Nabila El-Bassel
Paul Crits-Christoph
Edward V Nunes
Columbia University · USColumbia University Irving Medical Center · USHartford Financial Services (United States)New York University · USCouncil on Alcoholism and Drug Abuse · USMount Sinai Beth Israel · USNational Institute on Drug Abuse · USUniversity of Washington · US

Funding

The National Drug Abuse Treatment Clinical Trials NetworkU10DA013045 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LING, WALTER NMN · 1999 to 2015
$52.6M
CU PARTNERS: NY/LONG ISLAND REGIONAL NODEU10DA013035 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI NUNES, EDWARD V., ROTROSEN, JOHN P · 2001 to 2015
$47.6M
Clinical Trials Network, Ohio Valley Node U10DA013732U10DA013732 · NIDA · UNIVERSITY OF CINCINNATI · PI WINHUSEN, T JOHN · 2000 to 2015
$45.0M
Southern Consortium Node of the Clinical Trials NetworkU10DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2000 to 2015
$34.4M
Delaware Valley Node of the Clinical Trials NetworkU10DA013043 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI WOODY, GEORGE EDWARD · 1999 to 2015
$25.8M
CLINICAL TRIALS NETWORK: PACIFIC NORTHWEST NODEU10DA013714 · NIDA · UNIVERSITY OF WASHINGTON · PI DONOVAN, DENNIS MICHAEL, ROLL, JOHN M. · 2001 to 2015
$25.5M
CLINICAL TRIALS NETWORK: NEW ENGLAND NODEU10DA013038 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 1999 to 2010
$17.3M
NATIONAL DRUG ABUSE TREATMENT CLINICAL TRIALS NETWORKU10DA013711 · NIDA · DUKE UNIVERSITY · PI HUBBARD, ROBERT L. · 2001 to 2008
$14.7M
NIDA NIH HHS U10 DA013035NIDA NIH HHS U10 DA013038NIDA NIH HHS U10 DA013043NIDA NIH HHS U10 DA013045NIDA NIH HHS U10 DA013711NIDA NIH HHS U10 DA013714NIDA NIH HHS U10 DA013727NIDA NIH HHS U10 DA013732NIDA NIH HHS U10 DA13035NIDA NIH HHS U10 DA13038NIDA NIH HHS U10 DA13043NIDA NIH HHS U10 DA13045NIDA NIH HHS U10 DA13711NIDA NIH HHS U10 DA13714NIDA NIH HHS U10 DA13727NIDA NIH HHS U10 DA13732
6 · The paper itself

Abstract

contextBecause drug-involved women are among the fastest growing groups with AIDS, sexual risk reduction intervention for them is a public health imperative.

objectiveTo test effectiveness of HIV/STD safer sex skills building (SSB) groups for women in community drug treatment.

designRandomized trial of SSB versus standard HIV/STD Education (HE); assessments at baseline, 3 and 6 months.

participantsWomen recruited from 12 methadone or psychosocial treatment programs in Clinical Trials Network of National Institute on Drug Abuse. Five hundred fifteen women with >or=1 unprotected vaginal or anal sex occasion (USO) with a male partner in the past 6 months were randomized.

interventionsIn SSB, five 90-minute groups used problem solving and skills rehearsal to increase HIV/STD risk awareness, condom use, and partner negotiation skills. In HE, one 60-minute group covered HIV/STD disease, testing, treatment, and prevention information. MAIN OUTCOME: Number of USOs at follow-up.

resultsA significant difference in mean USOs was obtained between SSB and HE over time (F = 67.2, P < 0.0001). At 3 months, significant decrements were observed in both conditions. At 6 months, SSB maintained the decrease and HE returned to baseline (P < 0.0377). Women in SSB had 29% fewer USOs than those in HE.

conclusionsSkills building interventions can produce ongoing sexual risk reduction in women in community drug treatment.

Indexed as

Health EducationRisk Reduction BehaviorSubstance-Related DisordersAdultFemaleFollow-Up StudiesHealth Knowledge, Attitudes, PracticeHIV InfectionsHumansLogistic ModelsSubstance Abuse Treatment CentersSurveys and QuestionnairesUnsafe Sex

Identifiers

PMID18645513
PMCPMC2723122
OpenAlexW2077017758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.